Black Rock Inc. Axsome Therapeutics, Inc. Transaction History
Black Rock Inc.
- $4.23 Trillion
- Q1 2024
A detailed history of Black Rock Inc. transactions in Axsome Therapeutics, Inc. stock. As of the latest transaction made, Black Rock Inc. holds 3,195,490 shares of AXSM stock, worth $256 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
3,195,490
Previous 3,239,746
1.37%
Holding current value
$256 Million
Previous $258 Million
1.11%
% of portfolio
0.01%
Previous 0.01%
Shares
12 transactions
Others Institutions Holding AXSM
# of Institutions
290Shares Held
37.1MCall Options Held
401KPut Options Held
464K-
Rtw Investments, LP New York, NY4.49MShares$360 Million5.75% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.74MShares$300 Million0.01% of portfolio
-
Fairmount Funds Management LLC Philadelphia, PA2.36MShares$189 Million30.01% of portfolio
-
Deep Track Capital, LP Greenwich, CT1.3MShares$105 Million3.44% of portfolio
-
Ken Griffin Citadel Advisors LLC | Chicago, Il1.14MShares$91.7 Million0.02% of portfolio
About Axsome Therapeutics, Inc.
- Ticker AXSM
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 42,878,000
- Market Cap $3.44B
- Description
- Axsome Therapeutics, Inc., a biopharmaceutical company, engages in the development of novel therapies for central nervous system (CNS) disorders in the United States. The company's product pipeline includes AXS-05, a therapeutic for the treatment of major depressive disorder and resistant depression disorders; and that is in the Phase III clinic...